Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Funovics

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Progress in Clinical and Biological Research|January 1, 1987
The influence of septic shock on plasma proteins, lymphocytes and metabolic parametersE Roth, R Steininger, I Schindler, et al.
British Journal of Cancer|September 1, 1999
Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinomaW Scheithauer, G V Kornek, M Raderer, et al.
Cancer|June 22, 2000
A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinomaH Ulrich-Pur, G V Kornek, M Raderer, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Progress in Clinical and Biological Research|January 1, 1987
The influence of septic shock on plasma proteins, lymphocytes and metabolic parametersE Roth, R Steininger, I Schindler, et al.
British Journal of Cancer|September 1, 1999
Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinomaW Scheithauer, G V Kornek, M Raderer, et al.
Cancer|June 22, 2000
A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinomaH Ulrich-Pur, G V Kornek, M Raderer, et al.
Pageof 9